Institutional Best Practices for Treating Schizophrenia
EP. 1: Overview of Schizophrenia Treatment
ByPeter Salgo, MD, Columbia University Irving Medical Center ,Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center,Rahn Bailey, MD, DFAPA, Charles R. Drew University of Medicine and Science,Henry Nasrallah, MD, University of Cincinnati College of Medicine Joe Avelino, RN, BSN, MHSA, CPHQ, and Henry Nasrallah, MD, review schizophrenia and the needs of these patients.
EP. 2: Psychiatric Teams: Treating Schizophrenia Comorbidities
ByPeter Salgo, MD, Columbia University Irving Medical Center ,Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center,Rahn Bailey, MD, DFAPA, Charles R. Drew University of Medicine and Science,Henry Nasrallah, MD, University of Cincinnati College of Medicine Rahn Bailey, MD, DFAPA, and Henry Nasrallah, MD, discuss the challenges and unmet needs psychiatrists and their teams face when treating patients with schizophrenia and their multiple comorbidities.
EP. 3: Schizophrenia Relapse: Diagnosis, Prevention, and Impact
ByPeter Salgo, MD, Columbia University Irving Medical Center ,Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center,Rahn Bailey, MD, DFAPA, Charles R. Drew University of Medicine and Science,Henry Nasrallah, MD, University of Cincinnati College of Medicine Henry Nasrallah, MD, examines schizophrenia relapse, specifically how to diagnose and prevent it before further damage has transpired in the patient’s brain.
EP. 4: Increasing Patient Adherence to Schizophrenia Treatment Regimen
ByPeter Salgo, MD, Columbia University Irving Medical Center ,Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center,Rahn Bailey, MD, DFAPA, Charles R. Drew University of Medicine and Science,Henry Nasrallah, MD, University of Cincinnati College of Medicine Rahn Bailey, MD, DFAPA, and Henry Nasrallah, MD, explain how to increase patient adherence to treatment and address the stigma associated with schizophrenia even in the family of the patient.
EP. 5: Schizophrenia Burden
ByPeter Salgo, MD, Columbia University Irving Medical Center ,Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center,Rahn Bailey, MD, DFAPA, Charles R. Drew University of Medicine and Science,Henry Nasrallah, MD, University of Cincinnati College of Medicine A panel of experts in psychiatric treatment review the burden schizophrenia has on the health care system.
EP. 6: Introducing Long-Acting Injectables (LAIs) in Schizophrenia
ByPeter Salgo, MD, Columbia University Irving Medical Center ,Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center,Rahn Bailey, MD, DFAPA, Charles R. Drew University of Medicine and Science,Henry Nasrallah, MD, University of Cincinnati College of Medicine Henry Nasrallah, MD, recalls the history behind long-acting injectables in patients with schizophrenia.
EP. 7: Patient Factors Associated with Schizophrenia
ByPeter Salgo, MD, Columbia University Irving Medical Center ,Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center,Rahn Bailey, MD, DFAPA, Charles R. Drew University of Medicine and Science,Henry Nasrallah, MD, University of Cincinnati College of Medicine Henry Nasrallah, MD, discusses patient factors that lead to long-acting injectable treatment in patients with schizophrenia.
EP. 8: LAIs in Schizophrenia: Advantages and Techniques for Patient Acceptance
ByPeter Salgo, MD, Columbia University Irving Medical Center ,Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center,Rahn Bailey, MD, DFAPA, Charles R. Drew University of Medicine and Science,Henry Nasrallah, MD, University of Cincinnati College of Medicine Joe Avelino, RN, BSN, MHSA, CPHQ, reviews the benefits of using long-acting injectables (LAIs) and Henry Nasrallah, MD, reviews his techniques for getting patients to accept LAIs and continue with them.
EP. 9: Transitioning from Oral to LAIs to Manage Schizophrenia
ByPeter Salgo, MD, Columbia University Irving Medical Center ,Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center,Rahn Bailey, MD, DFAPA, Charles R. Drew University of Medicine and Science,Henry Nasrallah, MD, University of Cincinnati College of Medicine Henry Nasrallah, MD, and Rahn Bailey, MD, DFAPA, discuss how to switch a patient from oral to a long-acting injectable antipsychotic from their own experience.
EP. 10: Understanding When to Start LAIs in Schizophrenia
ByPeter Salgo, MD, Columbia University Irving Medical Center ,Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center,Rahn Bailey, MD, DFAPA, Charles R. Drew University of Medicine and Science,Henry Nasrallah, MD, University of Cincinnati College of Medicine Rahn Bailey, MD, DFAPA, and Henry Nasrallah, MD, review how early long-acting injectables should be started in patients with schizophrenia.
EP. 11: Lack of Guideline-Supported Protocols
ByPeter Salgo, MD, Columbia University Irving Medical Center ,Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center,Rahn Bailey, MD, DFAPA, Charles R. Drew University of Medicine and Science,Henry Nasrallah, MD, University of Cincinnati College of Medicine Joe Avelino, RN, BSN, MHSA, CPHQ, defines a hospital versus an institution; and Rahn Bailey, MD, DFAPA, and Henry Nasrallah, MD, discuss the lack of guideline-supported protocols for patients
EP. 12: Current Protocols in Psychiatric Care
ByPeter Salgo, MD, Columbia University Irving Medical Center ,Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center,Rahn Bailey, MD, DFAPA, Charles R. Drew University of Medicine and Science,Henry Nasrallah, MD, University of Cincinnati College of Medicine Henry Nasrallah, MD, compares the European Guidelines and United States Guidelines; the panel discusses guidelines currently in place for psychiatric patients.
EP. 13: Regulating the Practice of Psychiatry
ByPeter Salgo, MD, Columbia University Irving Medical Center ,Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center,Rahn Bailey, MD, DFAPA, Charles R. Drew University of Medicine and Science,Henry Nasrallah, MD, University of Cincinnati College of Medicine Experts in the field of psychiatry discuss the differences between other specialties and psychiatry as well as the inconsistency within psychiatry itself.
EP. 14: Best Practices: Transitioning from Inpatient to Outpatient
ByPeter Salgo, MD, Columbia University Irving Medical Center ,Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center,Rahn Bailey, MD, DFAPA, Charles R. Drew University of Medicine and Science,Henry Nasrallah, MD, University of Cincinnati College of Medicine Joe Avelino, RN, BSN, MHSA, CPHQ, describes the patient care protocols upon discharge from the inpatient setting to the outpatient setting to assure that patients will continue their care.
EP. 15: Under Prescribing LAIs: Understanding Why
ByPeter Salgo, MD, Columbia University Irving Medical Center ,Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center,Rahn Bailey, MD, DFAPA, Charles R. Drew University of Medicine and Science,Henry Nasrallah, MD, University of Cincinnati College of Medicine Rahn Bailey, MD, DFAPA, explains why long-acting injectables are under prescribed in patients with schizophrenia and why doctors choose not to use them as a first-line treatment.
EP. 16: Protocols for Frequently Hospitalized Patients
ByPeter Salgo, MD, Columbia University Irving Medical Center ,Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center,Rahn Bailey, MD, DFAPA, Charles R. Drew University of Medicine and Science,Henry Nasrallah, MD, University of Cincinnati College of Medicine Joe Avelino, RN, BSN, MHSA, CPHQ, and Rahn Bailey, MD, DFAPA, explain protocols a practice can follow when managing a patient with schizophrenia who is frequently hospitalized or has other medical conditions.
EP. 17: Schizophrenia: Practice, Patients, and Treatment
ByPeter Salgo, MD, Columbia University Irving Medical Center ,Joe Avelino, RN, BSN, MHSA, CPHQ, College Medical Center,Rahn Bailey, MD, DFAPA, Charles R. Drew University of Medicine and Science,Henry Nasrallah, MD, University of Cincinnati College of Medicine A panel of experts in schizophrenic psychiatric care share their thoughts on the practice, patients, and treatment based on their years of experience.
